Unlocking Data-Driven Approaches in Medicine and Pharmaceuticals

This document is a guide that outlines NTT DATA's vision for realizing data-driven transformation in the pharmaceutical and healthcare industries through the utilization of Real-World Data (RWD). It discusses the importance of collaboration among academia, medical institutions, and pharmaceutical companies to create patient-centric healthcare services. The guide emphasizes the need for a significant transformation of infrastructure and legal frameworks to facilitate the accumulation and utilization of medical data. Chapter 1 details the data-driven transformation of medical information and clinical trials, highlighting the challenges faced in drug development and the potential of AI and data analytics to enhance efficiency. Chapter 2 provides a global perspective on data-driven practices, examining the status of initiatives in the United States, China, and Europe, and the implications of regulatory frameworks on RWD utilization. The document concludes by addressing the current challenges and future directions for data-driven initiatives in Japan, emphasizing the need for learning from international examples.